Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience

BACKGROUND: Targeted next-generation sequencing (NGS) is frequently obtained at the University of California, Los Angeles (UCLA) for clinical characterization of CNS tumors. In this study, we describe the diagnostic reliability of the Foundation Medicine (FM) targeted NGS platform and its ability to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Matthew S, Eldred, Blaine S C, Liu, Regina, Pianka, Sean T, Molaie, Donna, Kevan, Bryan, Pan, Stephanie, Lai, Thomas J, Nguyen, Nhung T, Chow, Frances E, Yong, William H, Cox, Christopher D, Reeh, Devin N, Li, Tie, Liau, Linda M, Nghiemphu, Phioanh L, Cloughesy, Timothy F, Li, Gang, Lai, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034640/
https://www.ncbi.nlm.nih.gov/pubmed/32118206
http://dx.doi.org/10.1093/noajnl/vdaa009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034640/
https://www.ncbi.nlm.nih.gov/pubmed/32118206
http://dx.doi.org/10.1093/noajnl/vdaa009

Ejemplares similares